Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
-
As a result the gp V V
2018-10-30
As a result, the gp120 V1V2 region has been of intense interest owing to its immunogenic promise; however, V1V2 has proven difficult to characterize structurally. V1V2 has been observed in crystal structures in a variety of conformations. Bound to buy bupropion hydrochloride CH58 and CH59 isolated
-
Convincing vaccine hesitant patients to be vaccinated requir
2018-10-30
Convincing vaccine-hesitant patients to be vaccinated requires a response to GPs\' VH. Necessary steps include both better training and updating of GPs\' knowledge of vaccines\' benefits and risks: more time must be devoted to secretin receptor during medical studies than is currently spent. Traini
-
Recently we reported in a randomized
2018-10-30
Recently, we reported () in a randomized controlled trial that inhaled corticosteroid fluticasone propionate given over six months suppressed EMT-related changes in large airways of COPD patients. This trial showed marked reduction in EMT related changes in the active inhaled corticosteroids (ICS) c
-
T DM is diagnosed by
2018-10-30
T2DM is diagnosed by hyperglycemia (FPG>7.0mmol/l), which is associated with the established T2DM or with the terminal stage of development of T2DM. Therefore, it is obvious that measuring FPG cannot be used to predict years in advance whether the person have incipient diabetes. Currently, there is
-
The relative level of investment per death DALY or YLD
2018-10-30
The relative level of investment per death, DALY or YLD for all infections combined consistently increased over time (Tables 2–4). When considering time points 2004, 2010 and 2013, the median investment by mortality observed was £17.20, but greatest in 2013 (£31.16). HIV and malaria investments were
-
In addition ABC transporters are
2018-10-30
In addition, ABC-transporters are important markers for the isolation and analysis of stem TAK-242 and cancer propagating (stem) cells (Goodell et al., 1996; Zhou et al., 2001; Chiba et al., 2006; Haraguchi et al., 2006; Hirschmann-Jax et al., 2004; Kondo et al., 2004). We previously reported that
-
br Methods br Results VIS is an engineered human IgG
2018-10-30
Methods Results VIS410 is an engineered human IgG1 antibody that targets a unique, conserved conformational epitope on the stem of Influenza A virus HA protein (Tharakaraman et al., 2015). Previous studies have identified that VIS410 has broad reactivity against both group 1 and group 2 influe
-
Considering the role of the environment and gut microbiome
2018-10-30
Considering the role of the environment and gut microbiome in the pathobiology of the disease (Li and Jia, 2013; Wilson, 2009), a “pharmacometabolomics-aided pharmacogenomics” strategy could be of great benefit, as pharmacogenomics alone fails to address environmental influences. Taking into account
-
In summary we here provide insights into questions raised as
2018-10-30
In summary, we here provide insights into questions raised as a result of clinical experiences: How does clevidipine cause dyspnea relief in hypertensive AHF? What explains the specificity of this effect for clevidipine and not for other DHPs? What underlies the apparent potency differences between
-
Competencia es de inversi n e innovaci n estrat
2018-10-29
Competencia es de inversión e innovación estratégica. En el caso de Gruma esta es la forma de competencia dominante, la empresa ha invertido en general en desarrollar su escala y capacidad productiva, así como en su diversificación. Su estrategia de expansión ha seguido una senda de: 1. Crecimiento
-
Analyses of the transition of the initial
2018-10-29
Analyses of the transition of the initial MAβ preparation into nOAβ and fibrillar Aβ (FAβ) over time are shown in Fig. 2. Fig. 2a shows that the Aβ Fraction Soluble decreases to 0.3 after 40 days, indicating the increasing WEHI-539 manufacturer of insoluble aggregates. This decrease in Fraction Sol
-
Sitagliptin phosphate monohydrate br Experimental design mat
2018-10-29
Experimental design, materials and methods Conflicts of interest Acknowledgments This study was founded by grants from CNPq (Conselho Nacional do Desenvolvimento Científico e Tecnológico - process 302885/2011-0) and CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior). Mirian
-
ras gtpase br Experimental design materials and
2018-10-29
Experimental design, materials and methods Acknowledgements This work was supported by the Sichuan Provincial Department of Education (Grant number 12ZB064 to Li Wang), the Scientific Research Foundation of Southwest Medical University (Grant number 2012QN-05 to Li Wang), and the Doctoral Scie
-
br Experimental design materials and methods br Conflict of
2018-10-29
Experimental design, materials and methods Conflict of Interest The authors (KMK, JRR, MAB, KMR) of this AG-14361 manuscript (Functional magnetic resonance imaging data of incremental increases in visuo-spatial difficulty in an adult lifespan sample) have no conflicts of interest to report.
-
Despite the fact that all adolescents undergo development
2018-10-29
Despite the fact that all adolescents undergo development of these social and neural systems, engagement in risky behavior varies, with some far more likely than others to partake (Bjork and Pardini, 2015). One likely factor underlying individual differences in risk-taking behavior is function in so
15946 records 1054/1064 page Previous Next First page 上5页 10511052105310541055 下5页 Last page